STOCK TITAN

Akerna to Announce Financial Results for the First Quarter of 2022 on May 9, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Akerna (Nasdaq: KERN) will report its financial results for Q1 2022 on May 9, 2022, after market close. A conference call will follow on May 10, 2022, at 8:30 AM ET, where management will discuss the results and answer questions. Interested parties can join by phone or via a live webcast. Akerna is a SaaS company focused on the cannabis industry and has tracked over $30 billion in cannabis sales to date.

Positive
  • None.
Negative
  • None.

DENVER, April 27, 2022 /PRNewswire/ -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today announces that management will report its financial results for the first quarter ended March 31, 2022, after the close of trading on Monday, May 9, 2022. 

The company will subsequently host a conference call on the following morning, Tuesday May 10, 2022 at 8:30 AM ET to present its results to the investment community.  Management's prepared remarks will be followed by a live Q&A Session.

Any interested parties who would like to participate in the call by phone are encouraged to dial Toll-Free: 1-800-918-9481, or Toll / International: +1-212-271-4657 at least 5 minutes prior to the start of the call.  The Conference ID is 22018167.  The conference call will also be available via a live, listen-only webcast and can be accessed over the internet through the Investor Relations section of Akerna's website, https://ir.akerna.com/

To be included on the Company's email alerts list, please sign up at https://ir.akerna.com/news-events/email-alerts.

About Akerna
Akerna (Nasdaq: KERN) is an enterprise SaaS company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $30 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.  

The Company's cornerstone technology, MJ Platform, one of the world's leading cannabis infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators. Akerna also offers a complete suite of professional consulting services and data analytics for businesses as well as solo sciences, Leaf Data Systems, Trellis, Ample Organics, Viridian Sciences and 365 Cannabis.

To be included on the Company's email distribution list, please sign up at https://ir.akerna.com/news-events/email-alerts

For more information, visit https://www.akerna.com/.

Forward Looking Statements

Certain statements made in this release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding the intended date on which we will announce results for Q1 2022 and the timing for management's conference call in relation to our quarterly results. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include risks and uncertainties disclosed from time to time in Akerna's filings with the U.S. Securities and Exchange Commission, including those under the heading "Risk Factors" in the Company's latest annual report on Form 10-K filed on March 31, 2022 and in its subsequent reports. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akerna-to-announce-financial-results-for-the-first-quarter-of-2022-on-may-9-2022-301534157.html

SOURCE Akerna

FAQ

When will Akerna report its Q1 2022 financial results?

Akerna will report its Q1 2022 financial results on May 9, 2022, after market close.

What time is Akerna's conference call for Q1 2022 results?

Akerna's conference call for Q1 2022 results is scheduled for May 10, 2022, at 8:30 AM ET.

How can I participate in Akerna's conference call?

You can participate in Akerna's conference call by dialing 1-800-918-9481 or +1-212-271-4657, or you can join via the live webcast on their website.

Where can I find Akerna's financial results?

Akerna's financial results will be available on their Investor Relations website after the results are announced.

Akerna Corp.

NASDAQ:KERN

KERN Rankings

KERN Latest News

KERN Stock Data

162.32k
456.43k
1.06%
Health Information Services
Healthcare
Link
United States
Denver